Abstract
The care of patients transitioning from adolescence to adult life always raises challenges for the clinician. This has proven to be especially true in the case of growth hormone (GH) treatment, in part due to the absence of any immediately observable consequences of the cessation of therapy. This paper describes the challenges involved in reestablishing the diagnosis of GH deficiency (GHD), titrating GH dosage, and sustaining patients on long-term GH treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 645-649 |
| Number of pages | 5 |
| Journal | Journal of Pediatric Endocrinology and Metabolism |
| Volume | 16 |
| Issue number | SUPPL. 3 |
| State | Published - Oct 24 2003 |
Keywords
- Children
- Clinical trial
- Diagnosis
- IGF-1
- IGFBP-3
- Pubertal dosing
- Somatotropin
- Somatropin
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Endocrinology, Diabetes and Metabolism
- Endocrinology